Literature DB >> 24930128

Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations.

W Caleb Rutledge1, Nerissa U Ko, Michael T Lawton, Helen Kim.   

Abstract

Brain arteriovenous malformations (AVMs) are abnormal connections of arteries and veins, resulting in arteriovenous shunting of blood. Primary medical therapy is lacking; treatment options include surgery, radiosurgery, and embolization, often in combination. Judicious selection of AVM patients for treatment requires balancing risk of treatment complications against the risk of hemorrhage in the natural history course. This review focuses on the epidemiology, hemorrhage risk, and factors influencing risk of hemorrhage in the untreated natural course associated with sporadic brain AVM.

Entities:  

Mesh：

Year:  2014        PMID： 24930128      PMCID： PMC4139097          DOI： 10.1007/s12975-014-0351-0

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN： 1868-4483            Impact factor:   6.829


  51 in total

1.  Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations.

Authors:  Ludmila Pawlikowska; K Y Trudy Poon; Achal S Achrol; Charles E McCulloch; Connie Ha; Kristen Lum; Jonathan G Zaroff; Nerissa U Ko; S Claiborne Johnston; Stephen Sidney; Douglas A Marchuk; Michael T Lawton; Pui-Yan Kwok; William L Young
Journal:  Neurosurgery       Date:  2006-05       Impact factor: 4.654

2.  Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture.

Authors:  Yi Guo; Tara Saunders; Hua Su; Helen Kim; Deniz Akkoc; David A Saloner; Steven W Hetts; Christopher Hess; Michael T Lawton; Andrew W Bollen; Tony Pourmohamad; Charles E McCulloch; Tarik Tihan; William L Young
Journal:  Stroke       Date:  2012-02-02       Impact factor: 7.914

3.  Evaluating performance of the spetzler-martin supplemented model in selecting patients with brain arteriovenous malformation for surgery.

Authors:  Helen Kim; Tony Pourmohamad; Erick M Westbroek; Charles E McCulloch; Michael T Lawton; William L Young
Journal:  Stroke       Date:  2012-07-19       Impact factor: 7.914

4.  Characteristics of brain arteriovenous malformations with coexisting aneurysms: a comparison of two referral centers.

Authors:  Alexander X Halim; Vineeta Singh; S Claiborne Johnston; Randall T Higashida; Christopher F Dowd; Van V Halbach; Michael T Lawton; Daryl R Gress; Charles E McCulloch; William L Young
Journal:  Stroke       Date:  2002-03       Impact factor: 7.914

5.  Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment.

Authors:  Achal S Achrol; Helen Kim; Ludmila Pawlikowska; K Y Trudy Poon; Charles E McCulloch; Nerissa U Ko; S Claiborne Johnston; Michael W McDermott; Jonathan G Zaroff; Michael T Lawton; Pui-Yan Kwok; William L Young
Journal:  Neurosurgery       Date:  2007-10       Impact factor: 4.654

6.  Ferumoxytol-enhanced MRI to Image Inflammation within Human Brain Arteriovenous Malformations: A Pilot Investigation.

Authors:  David M Hasan; Matthew Amans; Tarik Tihan; Christopher Hess; Yi Guo; Soonmee Cha; Hua Su; Alastair J Martin; Michael T Lawton; Edward A Neuwelt; David A Saloner; William L Young
Journal:  Transl Stroke Res       Date:  2012-07       Impact factor: 6.829

7.  Gene microarray analysis of human brain arteriovenous malformations.

Authors:  Tomoki Hashimoto; Michael T Lawton; Gen Wen; Guo-Yuan Yang; Thomas Chaly; Campbell L Stewart; Holly K Dressman; Nicholas M Barbaro; Douglas A Marchuk; William L Young
Journal:  Neurosurgery       Date:  2004-02       Impact factor: 4.654

8.  Arteriovenous malformations of the brain: natural history in unoperated patients.

Authors:  P M Crawford; C R West; D W Chadwick; M D Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

9.  Concurrent arterial aneurysms in brain arteriovenous malformations with haemorrhagic presentation.

Authors:  C Stapf; J P Mohr; J Pile-Spellman; R R Sciacca; A Hartmann; H C Schumacher; H Mast
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

10.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Authors:  J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321
View more
  14 in total

1.  Integrin β8 Deletion Enhances Vascular Dysplasia and Hemorrhage in the Brain of Adult Alk1 Heterozygous Mice.

Authors:  Li Ma; Fanxia Shen; Kristine Jun; Chen Bao; Robert Kuo; William L Young; Stephen L Nishimura; Hua Su
Journal:  Transl Stroke Res       Date:  2016-06-29       Impact factor: 6.829

2.  Translational intracerebral hemorrhage: a need for transparent descriptions of fresh tissue sampling and preclinical model quality.

Authors:  Che-Feng Chang; Li Cai; Jian Wang
Journal:  Transl Stroke Res       Date:  2015-04-25       Impact factor: 6.829

3.  Association between Venous Angioarchitectural Features of Sporadic Brain Arteriovenous Malformations and Intracranial Hemorrhage.

Authors:  M D Alexander; D L Cooke; J Nelson; D E Guo; C F Dowd; R T Higashida; V V Halbach; M T Lawton; H Kim; S W Hetts
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-29       Impact factor: 3.825

Review 4.  Hematoma Expansion Following Intracerebral Hemorrhage: Mechanisms Targeting the Coagulation Cascade and Platelet Activation.

Authors:  Sherrefa R Burchell; Jiping Tang; John H Zhang
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

5.  Predictive Value of MRI in Diagnosing Brain AVM Recurrence after Angiographically Documented Exclusion in Children.

Authors:  A Jhaveri; A Amirabadi; P Dirks; A V Kulkarni; M M Shroff; N Shkumat; T Krings; V M Pereira; V Rea; P Muthusami
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-27       Impact factor: 3.825

6.  Fatal ruptured occult arteriovenous malformation in a young adult: An autopsy case report.

Authors:  Makiko Oomori; Sayaka Ito; Kazushi Higuchi
Journal:  Surg Neurol Int       Date:  2022-07-01

Review 7.  Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage.

Authors:  Richard F Keep; Ningna Zhou; Jianming Xiang; Anuska V Andjelkovic; Ya Hua; Guohua Xi
Journal:  Fluids Barriers CNS       Date:  2014-08-10

8.  Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation.

Authors:  Rachel Muster; Nerissa Ko; Wade Smith; Hua Su; Melissa A Dickey; Jeffrey Nelson; Charles E McCulloch; Patricia K Sneed; Jennifer L Clarke; David A Saloner; Laura Eisenmenger; Helen Kim; Daniel L Cooke
Journal:  BMJ Neurol Open       Date:  2021-03-17

9.  Dormant micro arteriovenous malformations lead to recurrent cerebral haemorrhage.

Authors:  Jun Cai; Hao Lin; Shaoxue Li; Zhimin Zou; Yanting Zhang; Shiwan Liu; Xin Chen; Xiaoxin Bai
Journal:  Springerplus       Date:  2016-07-11

10.  Histopathology of brain AVMs part II: inflammation in arteriovenous malformation of the brain.

Authors:  Roosa Wright; Patrik Järvelin; Henri Pekonen; Sara Keränen; Tuomas Rauramaa; Juhana Frösen
Journal:  Acta Neurochir (Wien)       Date:  2020-04-18       Impact factor: 2.216
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.